Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Advocacy Opportunity Treatment Guidelines

California Pharmacy & Therapeutics Committee to Hold Public Meeting

Agenda topics include topicals, GLP-1 drugs, biologics, PPI and H2 blockers, and more.

Read More →

September 21, 2026

NCCI Publishes Legislative & Regulatory Trends Report

Trending topics include worker classification, portable benefits, mental injuries, single-payer insurance, marijuana, and psychedelics.

Read More →

September 21, 2026

Advocacy Opportunity Treatment Guidelines

California Proposes MTUS Updates for Knee Disorders

The proposal would incorporate the latest ACOEM Guideline for knee disorders, and a public hearing is scheduled for October 16th.

Read More →

September 21, 2026

Advocacy Opportunity

Nevada to Hold Workshop Meeting for Streamlining Workers’ Comp Regulations

The meeting will take place September 24th, with agenda topics including provision of coverage, benefits for injury or death, and occupational diseases.

Read More →

September 21, 2026

Claim Costs Claim Data Pharmacy Data

California Publishes Report on Medical Service Cost Trends

Cost growth of services not subject to fee schedule caps has accelerated in recent years, driven largely by higher utilization.

Read More →

September 15, 2026

Ancillary Services Claim Data

WCRI Webinar Recap: Non-Price Controlled Services

Ambiguity for the billing of DME has led to significant increases in workers’ comp spend.

Read More →

September 15, 2026

Claim Costs Claim Data Pharmacy Data

WCRI Publishes 2026 CompScope Benchmarks

Many states experienced higher medical payments, driven by higher prices for professional services and evolving trends in prescription drug utilization.

Read More →

September 15, 2026

Industry Data

NCCI Publishes September Labor Market Insights

Leisure and hospitality had the largest growth of 62,000 jobs in August, bouncing back from declines in June and July.

Read More →

September 15, 2026

Advocacy Opportunity

Texas Proposes 2027 Workers’ Comp Research Agenda

Stakeholders can submit feedback on the research agenda through September 28th.

Read More →

August 31, 2026

« Previous 1 2 3 4 5 6 … 64 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduced significant implications for clinical research, drug development, and downstream utilization.

State of the Nation: Summer 2026

Healthesystems’ Sandy Shtab examines key workers’ comp policy trends, from PBM regulation and AI oversight to marijuana rescheduling and injured worker engagement.

Pennsylvania Proposes Reimbursement Caps for Compounds and Topicals

The bill would create a $400, 30-day supply cap for compound drugs.

New Jersey Proposes Marijuana Reimbursement in Workers’ Comp and Group Health

Companion bills S3984 and A1023 would require health insurance coverage for the medical use of cannabis under certain circumstances.

Florida Appeals Court Rules in Favor of Carriers and Employers on Physician-Dispensed Drugs

While injured workers have an absolute choice over their pharmacist, physicians are not considered pharmacists and therefore not entitled to reimbursement.